Chang C et al: Overview of penicillin allergy. Clinic Rev Allerg Immunol 2012;43:84.
Chovel-Sella A et al: The incidence of rash after amoxicillin treatment in children
Corey GR et al: Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: The SOLO II noninferiority study. Clin Infect Dis 2015;60:254.
DePestel DD et al: Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc 2008;48:530.
Fowler VG et al: Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653.
Jacoby GA, Munoz-Price LS: The new beta-lactamases. N Engl J Med 2005;352:380.
Keating GM, Perry CM: Ertapenem: A review of its use in the treatment of bacterial infections. Drugs 2005;65:2151.
Kerneis S et al: Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. Infect Dis 2015;47:789.
Lee SH et al: TarO-specific inhibitors of wall teichoic acid biosynthesis restore β-lactam efficacy against methicillin-resistant staphylococci. Sci Transl Med 2016;8:329.
with infectious mononucleosis. Pediatrics 2013;131:1424.
Leonard SN, Rybak MJ: Telavancin: An antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections. Pharmacotherapy 2008;28:458.
Mandell L: Doripenem: A new carbapenem in the treatment of nosocomial infections. Clin Infect Dis 2009;49(Suppl 1):S1.
Marston HD et al: Antimicrobial resistance. JAMA 2016;316:1193.
Noskin GA et al: National trends in Staphylococcus aureus infection rates: Impact on economic burden and mortality over a 6-year period. Clin Infect Dis 2007;45:1132.
Rybak M et al: Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the
Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009;66:82.
Sievart DM et al: Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008;46:668.
Tamma PD et al: The use of cefepime for treating AmpC β-lactamase-producing enterobacteriaceae. Clin Infect Dis 2013;57:781.
Van Duin D and Bonomo RA: Ceftazidime/avibactam and ceftolozane/tazobactam: Second-generation β-lactam/β-lactamase combinations. Clin Infect Dis 2016;63;234.